News Daily News No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI By Yael L. Maxwell April 22, 2020
News Daily News Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients By Michael O'Riordan April 21, 2020
News As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI By Michael O'Riordan April 17, 2020
News Daily News Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers By Michael O'Riordan April 15, 2020
News Daily News Who Should Head to the Cath Lab in the COVID-19 Pandemic? By Michael O'Riordan March 26, 2020
Presentation JIM 2020 Young patient with STEMI who overcomes any adverse event during primary PCI: Right device vs Murphy’s law Presenter: Riccardo Di Pietro February 15, 2020
Presentation JIM 2020 Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option Presenter: Marco Ferlini February 13, 2020
Presentation JIM 2020 What you should know about STEMI in 2020 (illustrated with STEMI cases) Presenter: Gianluca Campo February 12, 2020
Presentation TCT Abstracts Posters 2019 Intracoronary Tirofiban Delivered by Controlled Flow Infusion: Marked Reduction of Microvascular Obstruction in a Porcine STEMI Model Presenter: Robert Schwartz September 29, 2019